Novel eicosanoid derivatives

Details for Australian Patent Application No. 2010205816 (hide)

Owner Max-Delbruck-Centrum fur Molekulare Medizin

Inventors Schunck, Wolf-Hagen; Wallukat, Gerd; Fischer, Robert; Schmidt, Cosima; Muller, Dominik N.; Puli, Narender; Falck, John R.

Agent Watermark

Pub. Number AU-A-2010205816

PCT Pub. Number WO2010/081683

Priority 09000372.4 13.01.09 EP

Filing date 13 January 2010

Wipo publication date 22 July 2010

International Classifications

C07C 235/76 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/19 (2006.01)

A61K 31/336 (2006.01) - having three-membered rings, e.g. oxirane, fumagillin

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07C 275/20 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 303/38 (2006.01) Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/081683 Priority application(s): WO2010/081683

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010205825-Oxadiazole derivatives as SLPL receptor agonists

2010205815-Label film for deep-drawing processes